InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,733.20
(
0.06%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
83.03
(
-0.22%
)
Bitcoin
61,801.05
(
-1.75%
)
Post# of 251816
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: DewDiligence post# 183163

Friday, 10/24/2014 5:15:47 PM

Friday, October 24, 2014 5:15:47 PM

Post# of 251816
>>Urologists aren’t likely to cede this business without a fight.

No particular reason why urologists can't use Xtandi themselves. Zytiga requires concomitant long term steroids which they might not be comfortable with, but Xtandi AE profile not all that different from Lupron etc.

But agree SOC in this area changes very slowly.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up